Shigeru Kusumoto, Yasuhito Tanaka. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Hepacivirus/physiologyHepatitis B virus/physiologyHumansImmunosuppressive Agents/adverse effectsNeoplasms/drug therapyNeoplasms/immunologyRisk FactorsVirus Activation
Substances: See more » Immunosuppressive Agents
Year: 2014 PMID: 25154260 DOI: 10.2169/naika.103.1645
Source DB: PubMed Journal: Nihon Naika Gakkai Zasshi ISSN: 0021-5384